Recursion Pharmaceuticals’ $150 Million Private Placement

Davis Polk advised the placement agents in the transaction.Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the lead…

This content is for members only.
Login to Read More Join Now
Laura Testa

Author: Laura Testa

This content is for members only.
Login to Read More Join Now